"Gabe is terrific. He takes the client's interest to heart and you can guarantee that you will get 100% when he litigates a case on your behalf."
Chambers USA 2024
"An expert appellate attorney in the intellectual property space."
The Legal 500 US 2024
Next Generation Partner ‒ Patents: Litigation (Full Coverage)
The Legal 500 US 2024
IP Appellate Litigator of the Year
LMG Life Sciences 2023
Profile
Gabriel Bell is head of the firm’s Intellectual Property Appellate Practice and is regarded as one of the nation’s top IP appellate litigators. He represents market-leading technology and life sciences companies in the Federal Circuit and district courts. He is Chambers-ranked in IP Appellate and was recognized as the IP Appellate Litigator of the Year by LMG Life Sciences.
Gabriel combines his sophisticated technical knowledge with extensive experience in the Federal Circuit and federal district courts to guide clients across a broad range of sectors, including:
Computer
Telecommunication
Pharmaceutical
Biotech
Automotive
Financial
He has argued over 20 Federal Circuit appeals and has led and briefed dozens of others. He also routinely argues and briefs dispositive motions in district courts. He has particular expertise in patent eligibility under Section 101 of the Patent Act.
Gabriel serves as Co-Chair of the Federal Circuit Bar Association’s Scholarship Committee and maintains an active pro bono practice, including representing veterans in appeals.
Before joining Latham, Gabriel was counsel for the US Senate Committee on the Judiciary. He has also held positions at the US Department of Justice and NASA Langley Research Center. In addition, he clerked for judges on the D.C. and Fifth Circuits.
Gabriel is admitted to practice in the Supreme Court and the Fifth, Ninth, D.C., and Federal Circuits.
Experience
Gabriel’s representative clients include:
Abbott
Avadel CNS Pharmaceuticals
Duolingo
InfoBionic
J&J
Jaguar Land Rover North America
Natera
Meta
Peloton
Representative appellate victories in intellectual property matters include:
Latham litigators honored for successful outcomes in New York’s Appellate Division, First Department for Searchlight Capital Partners as well as at the US Internal Trade Commission on behalf of Serendia LLC.
For the third year in a row, Bloomberg Law has recognized the firm’s pro bono work, including our role in advising the Emmett Till Interpretive Center and securing a precedent-setting victory for US veterans.
Latham & Watkins secured a win for Serendia LLC when an administrative law judge ruled that four companies violated the Tariff Act of 1930, finding they infringed on four of Serendia’s patents used for novel radio frequency microneedling medical devices.
The US subsidiary of a South Korean dermatologist’s needle business, represented by Latham & Watkins, convinced a judge at the US International Trade Commission that several rivals in the marketplace for selling microneedles to plastic surgeons are infringing patents.
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.